The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025.

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...

Aurora Cannabis Inc (ACB) reports a robust quarter with significant increases in global medical cannabis revenue and a ...

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also suggests that the stock is experiencing more of a short cover rally ...

It was a big day for Canadian cannabis stock Aurora Cannabis (TSE:ACB), as it posted its earnings report with a hefty ...

Aurora Cannabis Inc. (TSE:ACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. Three ...

If the pot stock trade is done, someone forget to tell Aurora Cannabis, which is soaring on third quarter results.

(1) Working capital for the three months ended December 31, 2024 has been adjusted. Refer to discussion under "Liquidity and Capital Resources" section of the MD&A. View original content to ...

Aurora says net revenue for the three months ended Dec. 31, 2024 topped $88.1 million, up 37 per cent year-over-year. The ...